IFLR1000

CDH Genetech $1.18 billion acquisition of Sirtex Medical

14/6/2018
Public acquisition
Select tab

$ 1.18 billion

Announced

14/6/2018

Overview:

  • CDH Genetech has made a binding offer to Sirtex Medical's shareholders for the acquisition of 100% of the shares in the company.

Daniel Semerdzhiev - Data analyst

Jurisdiction:

Australia

Deal type:

Public acquisition

Practice area:

M&A

Governing law:

Australia

Industry sector:

Healthcare

Firms:
MinterEllison

Party: CDH Genetech (Acquirer)

Lawyer: David Inglis

Paul Hastings

Party: CDH Genetech (Acquirer)

Lawyers: Jordan Goldman, Quinn Dang, Vinnie Buehler

Watson Mangioni

Party: Sirtex Medical (Target)

Related deals